Clinical Trial: Phase I/IIa study evaluating NN2802 in healthy participants and in those with chronic spontaneous urticaria (CSU) who still have symptoms despite antihistamine treatment (China)

Posted On: 2026-10-16

China, Oct. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Phase I/IIa study evaluating NN2802 in healthy participants and in those with chronic spontaneous urticaria (CSU) who still have symptoms despite antihistamine treatment'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134508

Registration Time: 2026/10/15

Type: Interventional study

Primary Sponsor: Affiliated hangzhou first people's hospital, zhejiang university school of medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=347376

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Phase I/IIa study evaluating NN2802 in healthy participants and in those with chronic spontaneous urticaria (CSU) who still have symptoms despite antihistamine treatment (China)